Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Management
Company launches Paradigm 712 insulin pump with larger reservoir
November 24th, 2003
Medtronic, Inc., (MDT) announced the market introduction of its Paradigm 712 insulin pump, which incorporates a larger reservoir for diabetes patients requiring more insulin to keep their blood sugar levels within a normal range. The new pump, which was recently cleared by the U.S. Food and Drug Administration, is small, easy-to-use, and can replace insulin shots for many people using insulin to treat diabetes. The Paradigm 712 pump's larger reservoir is suited for children, young adults, insulin-resistant type 1 and type 2 patients, and women with gestational diabetes. The Paradigm 712 pump holds up to 300 units of insulin and is designed for...
Source: Obesity & Diabetes Week (2003-11-24)
|
